Abstract
Emerging antibiotic-resistant bacteria result in increased mortality and have negative economic impacts. It is necessary to discover new strategies to create alternative antibacterial agents that suppress the bacterial resistance mechanism and limit the spread of serious infectious bacterial diseases. Silver nanoparticles may represent a new medicinal agents as alternative antibiotics affect different bacterial mechanisms such as virulence and resistance. In addition to that of silver nitrate (AgNO3) and ampicillin, for the first time, the inhibitory effect of silver nanoparticles synthesized using Desertifilum sp. (D-SNPs) was evaluated against five pathogenic bacteria using the agar well diffusion method. Also, the influence of D-SNPs and AgNO3 on bacterial antioxidant and metabolic activities was studied. The antibacterial activity of D-SNPs and AgNO3 against methicillin-resistant Staphylococcus aureus (MRSA) strains was studied at the morphological and molecular level. D-SNPs and AgNO3 have the ability to inhibit the growth of the five bacterial strains and resulted in an imbalance in the CAT, GSH, GPx and ATPase levels. MRSA treated with D-SNPs and AgNO3 showed different morphological changes such as apoptotic bodies formation and cell wall damage. Moreover, both caused genotoxicity and denaturation of MRSA cellular proteins. Additionally, TEM micrographs showed the distribution of SNPs synthesized by MRSA. This result shows the ability of MRSA to reduce silver nitrate into silver nanoparticles. These data indicate that D-SNPs may be a significant alternative antibacterial agent against different bacteria, especially MDR bacteria, by targeting the virulence mechanism and biofilm formation, leading to bacterial death.
Highlights
Many pathogenic bacteria have become a principle cause of serious infectious diseases, and with the evolution of multidrug-resistant (MDR) bacteria, the problem has become more complicated (Brown and Wright, 2016)
The convergence of inhibition zone (IZ) diameter values of silver nanoparticles synthesized by Desertifilum sp (D-silver nanoparticles (SNPs)) and ampicillin antibiotic against methicillin-resistant Staphylococcus aureus (MRSA) indicates that D-SNPs act as a promising antibacterial agent, especially against MDR bacteria
Biogenic silver nanoparticles may represent a new chance in the medical fields because they can act as alternative antibiotics that affect different bacterial mechanisms such as virulence and resistance
Summary
Many pathogenic bacteria have become a principle cause of serious infectious diseases, and with the evolution of multidrug-resistant (MDR) bacteria, the problem has become more complicated (Brown and Wright, 2016). The multi-drug-resistant bacteria problem is growing rapidly due to the uncontrolled and indiscriminate usage of antibiotics for the treatment of bacterial infections (Yah and Simate, 2015). The overloading usage of antibiotics can result in issues such as MDR bacterial spread, prolonged infection treatment and high mortality risk (Yah and Simate, 2015). Both gram-negative and gram-positive bacteria include members that are distinguished as MDR bacteria or those sensitive to antibiotics (Cillóniz et al, 2019; Koulenti et al, 2019). Endocarditis, osteomyelitis, necrotizing pneumonia and sepsis infections occur when these bacteria disseminate into the blood stream (Lowy, 1998)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.